首页> 美国卫生研究院文献>Cancers >Study of the Genetic Variants in BRCA1/2 and Non-BRCA Genes in a Population-Based Cohort of 2155 Breast/Ovary Cancer Patients Including 443 Triple-Negative Breast Cancer Patients in Argentina
【2h】

Study of the Genetic Variants in BRCA1/2 and Non-BRCA Genes in a Population-Based Cohort of 2155 Breast/Ovary Cancer Patients Including 443 Triple-Negative Breast Cancer Patients in Argentina

机译:在阿根廷的3155名乳腺/卵巢癌患者中在2155名乳腺/卵巢癌症患者中的BRCA1 / 2和非BRCA基因中的遗传变异研究包括443名三阴性乳腺癌患者阿根廷

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gene/s sequencing in hereditary breast/ovary cancer (HBOC) in routine diagnosis is challenged by the analysis of panels. The aim of this report is to describe a retrospective analysis of BRCA1/2 and non-BRCA gene sequencing in patients with breast/ovary cancer (BOC), including triple-negative breast cancer (TNBC). TNBC is associated to BRCA1/2 at a higher rate than the rest of the breast cancer types. The more prevalent pathogenic variants (PVs) in BRCA1/2 genes do not rule out the importance to panels of genes, although they are certainly far from shedding light on the gap of the 85% predicted linkage association of BOC with BRCA1/2 and are still not elucidated. This data is also of value in health programming for alerting risks in breast screening and knowledge of the regional spectrum of genetic variants.
机译:在常规诊断中遗传乳房/卵巢癌(HBOC)的基因/ S测序受到面板分析的挑战。本报告的目的是描述乳腺/卵巢癌(BOC)患者BRCA1 / 2和非BRCA基因测序的回顾性分析,包括三阴性乳腺癌(TNBC)。 TNBC以比其他乳腺癌类型的速率更高的BRCA1 / 2与BRCA1 / 2相关联。 BRCA1 / 2基因中普遍普遍的致病变体(PVS)不会排除对基因面板的重要性,尽管它们肯定远离脱光,但在BCA1 / 2中的85%预测联系协会的差距上脱落。仍然没有犹豫。该数据也具有卫生编程的价值,以提示乳房筛选和遗传变异区域谱的知识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号